Geniecare Inc.

Geniecare Inc. is a biotech company focusing on the R&D, production, marketing and sales, and technical service of precision diagnostics in the field of animal diseases. We are committed to providing customers with comprehensive, fast, accurate and quality diagnostic products and technology service for animal diseases, building an overall ecosystem for animal diseases diagnostics, especially in the scope of precision medicine, empowering rapid and precise diagnostics of animal diseases with scientific and technological innovation, boosting the healthy development of biosecurity in the global livestock industry, and promoting the common well-being of human and animal health. Geniecare is an affiliated company of Sansure Biotech Inc. (Stock Code: 688289), a leading enterprise in gene technology. Sansure is an in vitro diagnostic solution provider integrating diagnostic reagents, instruments and independent clinical laboratory services with its own innovative gene technology as its core. Its products serve more than 160 countries and regions around the world. Geniecare owns thousands of square meters of clean workshops and laboratories dedicated for manufacturing of nucleic acid test kits and immunology diagnostic kits in compliance with the GMP standards for veterinary drugs, and maintains good relationship with domestic prestigious agricultural colleges and authoritative experts in the mode of industry-university-research cooperation. At present, Geniecare has independently developed diagnostic instruments and reagents for companion animal diseases and livestock diseases. Geniecare customizes multi-throughput diagnostic solutions for diverse applications in pastures, forest zones, breeding farms and animal hospitals; it can also provide "turnkey" solutions for standard labs, covering molecular biology, immunology, microbiology and other technology platforms, to realize the full-range and one-stop services including instruments training and technical support.

• Employees 200
• Founded 2021